Patients with RASopathies are known to be at increased risk of cancer development, CBL syndrome is associated with an increased risk of JMML and CBL mutations occurs in of a variety of myeloid neoplasms [7, 8]. Here, CBL is linked to juvenile myelomonocytic leukemia.